Hyperinsulinemia Impaired Coronary Collateral Circulation in Patients with Chronic Total Coronary Occlusion

References

• Liu T, Wu Z, Liu J, Lv Y, Li W. Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: an observational study. Cardiovasc Diabetol. 2021;20(1):104. doi:10.1186/s12933-021-01297-4
   PubMed Web of Science ®Google Scholar
• van Veelen A, Claessen BEPM, Houterman S, et al. PCI Registration Committee of the Netherlands Heart Registration. Incidence and outcomes of chronic total occlusion percutaneous coronary intervention in the Netherlands: data from a nationwide registry. Neth Heart J. 2021;29(1):4–13. doi:10.1007/s12471-020-01521-y
   PubMed Web of Science ®Google Scholar
• Wu WT, Lin TH, Hsu PC, Lai WT, Sheu SH. Prediction for coronary collateral development. Acta Cardiol Sin. 2022;38(1):27–28. doi:10.6515/ACS.202201_38(1).20211208A
   PubMed Web of Science ®Google Scholar
• Das S, Goldstone AB, Wang H, et al. A unique collateral artery development program promotes neonatal heart regeneration. Cell. 2019;176(5):1128–1142. doi:10.1016/j.cell.2018.12.023
   PubMed Web of Science ®Google Scholar
• Jamaiyar A, Juguilon C, Dong F, et al. Cardioprotection during ischemia by coronary collateral growth. Am J Physiol Heart Circ Physiol. 2019;316(1):H1–H9. doi:10.1152/ajpheart.00145.2018
   PubMed Web of Science ®Google Scholar
• Xun P, Wu Y, He Q, He K. Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2013;98(6):1543–1554. doi:10.3945/ajcn.113.065565
   PubMed Web of Science ®Google Scholar
• Yaghootkar H, Scott RA, White CC, et al. Genetic evidence for a normal-weight “metabolically obese” phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes. Diabetes. 2014;63:4369–4377. doi:10.2337/db14-0318
   PubMed Web of Science ®Google Scholar
• Tan Q, Li Y, Li X, Zhang S. Hyperinsulinemia impairs functions of circulating endothelial progenitor cells. Acta Diabetol. 2019;56(7):785–795. doi:10.1007/s00592-019-01314-9
   PubMed Web of Science ®Google Scholar
• Tan Q, Chen M, Hao J, Wei K. Impact of hyperinsulinemia on long-term clinical outcomes of percutaneous coronary intervention in patients without diabetes who have acute myocardial syndrome. Diabetes Metab Syndr Obes. 2021;7(14):3949–3957. doi:10.2147/DMSO.S318852
   Google Scholar
• Tan Q, Zhang S, Li Y. Circulating endothelial progenitor cells were decreased in patients with metabolic syndrome. Clin Lab. 2018;64(10):1679–1683. doi:10.7754/Clin.Lab.2018.180427
   PubMed Web of Science ®Google Scholar
• Reto BM, Seiler C. The Human Coronary Collateral Circulation, Its Extracardiac Anastomoses and Their Therapeutic Promotion. Int J Mol Sci. 2019;20(15):3726. doi:10.3390/ijms20153726.
   PubMed Web of Science ®Google Scholar
• Li Y, Tan Q, Guo Y, et al. The influence of exercise training on endothelial function, serum irisin and inflammatory markers in the elderly with metabolic syndrome. Clin Lab. 2021;67(3). doi:10.7754/Clin.Lab.2020.200446
   Web of Science ®Google Scholar
• Pei J, Wang X, Xing Z. Traditional cardiovascular risk factors and coronary collateral circulation: a meta-analysis. Front Cardiovasc Med. 2021;8:743234. doi:10.3389/fcvm.2021.743234
   PubMed Web of Science ®Google Scholar
• Janssen JA. Hyperinsulinemia and its pivotal role in aging, obesity, type 2 diabetes, cardiovascular disease and cancer. Int J Mol Sci. 2021;22(15):7797. doi:10.3390/ijms22157797
   PubMed Web of Science ®Google Scholar
• Sbraccia P, D’Adamo M, Guglielmi V. Is type 2 diabetes an adiposity-based metabolic disease? From the origin of insulin resistance to the concept of dysfunctional adipose tissue. Eat Weight Disord. 2021;26:2429–2441. doi:10.1007/s40519-021-01109-4
   PubMed Web of Science ®Google Scholar
• Sabra M, Karbasiafshar C, Aboulgheit A, Raj S, Abid MR, Sellke FW. Clinical application of novel therapies for coronary angiogenesis: overview, challenges, and prospects. Int J Mol Sci. 2021;22(7):3722. doi:10.3390/ijms22073722
   PubMed Web of Science ®Google Scholar
• Melincovici CS, Boşca AB, Şuşman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455–467.
   PubMed Web of Science ®Google Scholar
• Chen Z, Haus JM, Chen L, et al. CCL28-induced CCR10/eNOS interaction in angiogenesis and skin wound healing. FASEB J. 2020;34(4):5838–5850. doi:10.1096/fj.201902060R
   PubMed Web of Science ®Google Scholar
• Adali MK, Buber I, Sen G, Yilmaz S. Relationship between systemic immune-inflammation index and coronary collateral circulation in patients with chronic total occlusion. Arq Bras Cardiol. 2022;119(1):69–75. doi:10.36660/abc.20210414
   PubMed Web of Science ®Google Scholar
• Mackesy DZ, Goalstone ML. Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells. J Inflamm. 2011;8:34–38. doi:10.1186/1476-9255-8-34
   Google Scholar
• Flores-Umanzor EJ, Ortega-Paz L, Cepas-Guillen PL, et al. Endothelial progenitor cell function in patients with coronary chronic total occlusion and its relationship with collateral circulation. J Invasive Cardiol. 2021;33(10):E809–E816.
   PubMed Web of Science ®Google Scholar
• Mackesy DZ, Goalstone ML. Extracellular signal-regulated kinase-5: novel mediator of insulin and tumor necrosis factor α-stimulated vascular cell adhesion molecule-1 expression in vascular cells. J Diabetes. 2014;6(6):595–602. doi:10.1111/1753-0407.12132
   PubMed Web of Science ®Google Scholar
• Mahmoud AM, Szczurek MR, Blackburn BK, et al. Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles. Physiol Rep. 2016;4(16):e12895. doi:10.14814/phy2.12895
   PubMedGoogle Scholar